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Selection and maturation in the thymus is a complex and deadly process. The majority of thymocytes are either non-selected or negatively selected and die in the thymus via apoptosis (for review see 1, 2, 3). Our laboratory and others have previously shown that galectin-1, a lectin expressed in the thymus, spleen, lymph nodes, and other tissues, can induce apoptosis of immature thymocytes, but not mature thymocytes. This suggests that galectin-1 may participate in apoptosis of negatively selected and non-selected thymocyte populations (4, 5) . Galectin-1 also induces apoptosis of activated T cells, but not resting T cells, implying that galectin-1 may also play a role in terminating an immune response in the periphery (6) .
To understand the mechanism of galectin-1 induced apoptosis, it is critical to define the oligosaccharide ligands on the surface of T cells that are recognized by galectin-1. Previous studies have shown that lactosamine (Galβ1-4GlcNAc) is the preferred minimal saccharide ligand bound by galectin-1. Galectin-1 has a relatively low affinity for single N-acetyllactosamine sequences; however, galectin-1 binds with high avidity to glycans containing multiple Nacetyllactosamine units and preferentially binds glycoproteins containing linear polylactosamine sequences (7) (8) (9) (10) (11) . These linear polylactosamine sequences can be found on O-linked and N-linked glycans (Scheme 1). On O-glycans, the addition of polylactosamine sequences is primarily controlled by the activity of the core 2 β-1,6-N-acetylglucosaminyltransferase (core 2 GnT) 1 (12) (13) (14) . This enzyme transfers a GlcNAc residue to a GalNAc residue on the core 1 O-glycan structure, creating the core 2 branch (15) . Subsequently, repeating lactosamine sequences can be added to this branch (16, 17) . The β-1,6-N-acetylglucosaminyltransferase V enzyme (GnT V) can regulate the formation of linear polylactosamine chains on N-glycans (18) . The GnT V enzyme transfers a GlcNAc to a mannose residue on the trimannosyl core of N-linked glycans, creating a by guest on http://www.jbc.org/
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branched acceptor on which polylactosamine can be added to either the GlcNAcβ-1,2-Man or
GlcNAcβ-1,6-Man sequences (19) (20) (21) (22) . In the human thymus, expression of the core 2 GnT is largely restricted to cortical thymocytes (23) . In contrast, the GnT V is expressed in all subsets of human thymocytes (M. Pang, M. Pierce, and L.G. Baum, unpublished data). Expression of the core 2 GnT has also been shown to regulate leukocyte function in the periphery. T lymphocytes from core 2 GnT transgenic mice demonstrated reduced immune responses, resulting from alterations in cell-cell interactions (24) . In addition, recent work has found that the epitope created by the core 2 GnT is not detected on naive peripheral T cells, but is expressed at high levels on antigen specific effector T cells, following an immune response. This epitope is not detected on antigen specific memory T cells, suggesting that core 2 GnT expression is important in discriminating between effector and memory T cells (25) . However, the precise functions of the core 2 GnT and the GnT V in thymocyte development have not been elucidated.
While it is clear that galectin-1 preferentially binds to polylactosamine sequences, it is not know whether N-linked or O-linked polylactosamine sequences on T cell surface glycoproteins participate in galectin-1 apoptosis. Since the core 2 GnT and the GnT V can both create the oligosaccharide scaffolds on which polylactosamine units can be added, we asked whether expression of these two enzymes regulates the susceptibility of T cells to galectin-1. To examine the roles of the core 2 GnT and the GnT V in galectin-1 apoptosis, we used two murine cell lines, the BW5147 T cell lymphoma and a derivative of this line, PHA R 2.1. The PHA R 2.1 cell line was generated by mutagenesis and selection for resistance to the cytotoxic lectin L-PHA that recognizes the oligosaccharide structure generated by the GnT V (26). BW5147 cells have high levels of GnT V activity, while PHA R 2.1 cells lack GnT V activity (27 Core 2 GnT expression regulates T cell apoptosis.
Experimental Procedures

Reagents and Cells
Galectin-1 was prepared as described previously (6 The Lck-mC2GnT transgenic mice, overexpressing the core 2 GnT in T cells, were on the FVB/N background and were described previously (24) . Age-matched, wildtype FVB/N mice were used as controls. The core 2 GnT transgenic mice used in this study were 5-8 weeks old.
Galectin-1 apoptosis assays
The BW5147 and PHA 
RT-PCR analysis
First strand cDNA synthesis was performed using the Ready to Go T-Primed First Strand kit (Pharmacia Biotech, Piscataway, New Jersey) using 5 µg total RNA from either BW5147 cells or mf using an Invitrogen Electroporator II. Cells were added to 20 ml of complete DMEM and cultured for two days. Cells were split 1:10 into fresh DMEM containing Zeocin (final concentration of 500 µg/ml) to select for transfectants. Cells were washed with selective media every 3 days. Individual clones were isolated by limiting dilution.
Results
T cells that are susceptible to galectin-1 induced apoptosis express core 2 O-linked oligosaccharides
Since galectin-1 preferentially binds to polylactosamine sequences in solution, we asked whether polylactosamine sequences on T cell surface glycoproteins are important for galectin-1 induced death. We examined two murine T cell lines to determine whether differential expression of two key enzymes that regulate the expression of polylactosamine also regulate susceptibility to galectin-1 induced apoptosis. As previously shown, BW5147 cells express the GnT V, while PHA R 2.1 cells do not express the GnT V (27) . Unexpectedly, we found that BW5147 and To determine whether expression of the core 2 GnT or the GnT V was necessary for galectin-1 mediated death, we examined the BW5147 and PHA 
Core 2 GnT expression is necessary for galectin-1 induced death of BW5147 cell line
Since expression of the oligosaccharide created by the core 2 GnT correlated with susceptibility to galectin-1 induced apoptosis, we asked whether the expression of the core 2 GnT enzyme was sufficient to render BW5147 cells susceptible to galectin-1. BW5147 cells were transfected with a vector containing core 2 GnT cDNA or with vector alone (mock transfectant). 
Overexpression of the core 2 GnT in murine thymocytes results in increased galectin-1 induced apoptosis
Our group has previously shown that the core 2 GnT is highly expressed in the cortex of the human thymus, while there is minimal expression of the core 2 GnT in the medulla (23) . Further, the majority of human and murine double positive (DP) thymocytes express high levels of core 2 O-glycans, while single positive (SP) thymocytes do not (23, 29, 31) . As shown in Fig. 4A , approximately 75% of DP thymocytes expressed the 1B11 epitope. Expression of the core 2 GnT in the DP thymic population correlates with susceptibility to galectin-1 apoptosis as human and murine DP thymocytes are most susceptible to galectin-1 mediated death (4, 5) . Core 2 GnT expression regulates T cell apoptosis.
14 To investigate whether increased expression of the core 2 GnT in vivo would regulate susceptibility to galectin-1 mediated cell death, we examined thymocytes from core 2 GnT transgenic mice. In these mice, core 2 GnT expression is regulated by the Lck promoter, so that overexpression of the core 2 GnT is limited to thymocytes and T cells (24) . As shown in Fig. 4B, there is a high level of expression of the 1B11 epitope on all thymocytes from the core 2 GnT transgenic mice. To investigate whether core 2 GnT overexpression affected susceptibility to galectin-1, thymocytes from the core 2 GnT transgenic mice and wildtype mice were incubated with galectin-1 or control buffer and the number of viable DP and SP thymocytes in the galectin-1 treated samples and the control samples was determined. As shown in Fig. 4C , there was no significant galectin-1 induced cell loss of SP thymocytes from either the wildtype or the core 2
GnT mice. However, analysis of the DP thymocyte population demonstrated that galectin-1 eliminated a greater percent of the DP thymocytes from the transgenic mice (67% cell loss) compared to DP thymocytes from wildtype mice (48% cell loss). In three independent experiments, we observed a 20-60% increase in the level of galectin-1 induced apoptosis in the DP thymocyte population from the core 2 GnT transgenic mice, compared to the DP thymocyte population from wildtype mice (Fig. 4D) . Thus, overexpression of the core 2 GnT resulted in increased susceptibility of DP thymocytes to galectin-1, but did not affect the susceptibility of SP thymocytes to galectin-1. sialyltransferase regulated the susceptibility of B cell lines to Fas induced apoptosis (32) . Second, the oligosaccharide structures created by the glycosyltransferases must be linked to glycolipids or glycoproteins on the T cell surface that can transduce the death signal. Finally, the T cell must express the internal components of the apoptotic machinery for the galectin-1 death signal to be sent to completion.
The aim of the present study was to identify the oligosaccharide ligands that participate in the transduction of the galectin-1 death signal by focusing on the enzymes that regulate polylactosamine synthesis, the GnT V and the core 2 GnT. As shown in Core 2 GnT expression regulates T cell apoptosis.
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of T lymphocytes that are susceptible to galectin-1 (4-6). As shown in Fig. 4C and 4D, we found increased galectin-1 induced cell death of DP thymocytes from the core 2 GnT transgenic mice compared to DP thymocytes from wildtype mice. This indicated that expression of the core 2 GnT could confer galectin-1 susceptibility to a subset of DP thymocytes. However, SP thymocytes from core 2 GnT transgenic mice remained insensitive to galectin-1 apoptosis. Therefore, expression of the core 2 GnT alone is not sufficient to render mature thymocytes susceptible to galectin-1 apoptosis.
These data reveal that the regulation of galectin-1 susceptibility occurs at several cellular levels. Since overexpression of the core 2 GnT in mature SP thymocytes did not render these cells susceptible to galectin-1, SP thymocytes may not have the internal apoptotic machinery required for galectin-1 induced cell death. The intracellular galectin-1 death pathway may be blocked at some point or a separate anti-apoptotic signal could override the galectin-1 death message.
In contrast, DP thymocytes have the internal apoptotic pathway required for galectin-1 mediated cell death. If DP thymocytes express the core 2 GnT, galectin-1 binding can trigger the death pathway. However, in wildtype mice, a subset of DP thymocytes do not express the core 2
GnT, and thus may not synthesize an essential galectin-1 ligand. Ellies, et al., have shown that expression of the core 2 GnT is downregulated during positive selection of murine thymocytes (31). When we examined DP thymocytes from wildtype mice for expression of core 2 O-glycans, there was a small population of DP thymocytes (approximately 25%) that had diminished expression of core 2 O-glycans (Fig. 4A ). This fraction is roughly equivalent to the fraction of thymocytes from the core 2 GnT transgenic mice demonstrating increased susceptibility to galectin-1 (Fig. 4C) . These data indicate that there is a subset of DP thymocytes that remain susceptible to galectin-1 if the saccharide ligand created by the core 2 GnT is expressed. Thus, our results suggest that in thymic development, there is a narrow developmental window during which loss of core 2 GnT expression precedes downregulation of the galectin-1 apoptotic machinery. The 20-60% increase in galectin-1 induced cell death of the DP thymocytes from the core 2 GnT mice, compared to that from wildtype mice (Fig. 4C) , may appear modest. However, this difference could have a significant biological effect during the selection process where the additional loss of DP thymocytes could adversely impact the total repertoire.
Expression of specific T cell surface glycoproteins containing the core 2 O-linked oligosaccharides may be another factor regulating galectin-1 mediated apotosis. The core 2 GnT is known to modify oligosaccharide structures on a number of T cell glycoproteins, including CD43
and CD45 (30, 34) . CD45 and CD43 are heavily glycosylated proteins that are expressed at high levels on the surface of the BW5147 and PHA The core GnT appears to play an important role in many immune processes. Expression of the core 2 GnT enzyme has recently been shown to be necessary for proper function of the innate immune system, as this enzyme can also regulate synthesis of ligands for the selectin family of cell adhesion molecules (37) . Disregulation of core 2 GnT expression has been observed in several immune disorders, such as Wiskott-Aldrich Syndrome, leukemia, and AIDS (38-42).
Mukasa, et al., have recently found that core 2 GnT expression is increased on a subset of human peripheral T cells compared to naive T cells (43) . Importantly, the 1B11 antibody, that recognizes an epitope created by the core 2 GnT, appears to discriminate effector from memory T cells (25) .
This implies that core 2 GnT activity is high in effector cells, but low in memory cells (26) 
